CIK 0001411685 · Non-accelerated filer<br>Smaller reporting company
Vistagen Therapeutics, Inc.
Sign in to watch- Ticker
- VTGN
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Mar 31
- Incorporated
- NV
- Entity type
- operating
- EIN
- 205093315
- Phone
- 650-577-3600
- Business address
- 343 ALLERTON AVENUE, SOUTH SAN FRANCISCO, CA, 94080
- Former names
- Excaliber Enterprises, Ltd.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 51 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2019-05-23 | MCPARTLAND MARK A. VP CORPORATE DEVELOPMENT | Grant or award · Stock Option (Right to Buy) | +150,000 | 150,000 | ||
| 2019-05-23 | DOTSON JERROLD DUANE VP, CFO AND SECRETARY | Grant or award · Stock Option (Right to Buy) | +150,000 | 150,000 | ||
| 2019-05-23 | Singh Shawn CHIEF EXECUTIVE OFFICER | Grant or award · Stock Option (Right to Buy) | +80,000 | 80,000 | ||
| 2019-03-14 | SAXE JON S Director | Purchase | +7,920 | $1.27 | $10K | 20,000 |
| 2019-03-13 | SAXE JON S Director | Purchase | +12,080 | $1.26 | $15K | 12,080 |
| 2019-03-13 | SNODGRASS H. RALPH PRES./CHIEF SCIENTIFIC OFFICER | Option exercise | +2,500 | $1.50 | $4K | 62,724 |
| 2019-03-13 | SNODGRASS H. RALPH PRES./CHIEF SCIENTIFIC OFFICER | Option exercise · Stock Option (Right to Buy) | −2,500 | 0 | ||
| 2019-01-29 | SAXE JON S Director | Option exercise | +375 | $1.50 | $563 | 2,251 |
| 2019-01-29 | SAXE JON S Director | Option exercise | +1,000 | $1.50 | $2K | 3,251 |
| 2019-01-29 | SAXE JON S Director | Option exercise · Stock Option (Right to Buy) | −375 | 0 | ||
| 2019-01-29 | SAXE JON S Director | Option exercise · Stock Option (Right to Buy) | −1,000 | 0 | ||
| 2019-01-14 | Singh Shawn CHIEF EXECUTIVE OFFICER | Option exercise | +21,250 | $1.50 | $32K | 21,250 |
| 2019-01-14 | Singh Shawn CHIEF EXECUTIVE OFFICER | Option exercise | +1,125 | $1.50 | $2K | 22,375 |
| 2019-01-14 | Singh Shawn CHIEF EXECUTIVE OFFICER | Option exercise | +3,000 | $1.50 | $5K | 25,375 |
| 2019-01-14 | Singh Shawn CHIEF EXECUTIVE OFFICER | Option exercise · Stock Option (Right to Buy) | −21,250 | 0 | ||
| 2019-01-14 | Singh Shawn CHIEF EXECUTIVE OFFICER | Option exercise · Stock Option (Right to Buy) | −1,125 | 0 | ||
| 2019-01-14 | Singh Shawn CHIEF EXECUTIVE OFFICER | Option exercise · Stock Option (Right to Buy) | −3,000 | 0 | ||
| 2019-01-14 | Singh Shawn CHIEF EXECUTIVE OFFICER | Grant or award · Stock Option (Right to Buy) | +220,000 | $1.70 | $374K | 220,000 |
| 2019-01-10 | Cunningham Ann Michelle Director | Grant or award · Stock Option (Right to Buy) | +25,000 | 25,000 | ||
| 2018-08-29 | Singh Shawn CHIEF EXECUTIVE OFFICER | Returned to the company · Stock Option (Right to Buy) | −3,000 | 0 |
Page 9 of 17 · 323 trades